KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Aquestive Therapeutics (AQST) Other Non Operating Income (2019 - 2023)

Historic Other Non Operating Income for Aquestive Therapeutics (AQST) over the last 2 years, with Q4 2023 value amounting to -$1.0 million.

  • Aquestive Therapeutics' Other Non Operating Income changed N/A to -$1.0 million in Q4 2023 from the same period last year, while for Sep 2024 it was -$1.0 million, marking a year-over-year decrease of 19150.14%. This contributed to the annual value of -$1.4 million for FY2023, which is N/A changed from last year.
  • Per Aquestive Therapeutics' latest filing, its Other Non Operating Income stood at -$1.0 million for Q4 2023.
  • Over the past 5 years, Aquestive Therapeutics' Other Non Operating Income peaked at -$353000.0 during Q1 2023, and registered a low of -$4.9 million during Q3 2019.